Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 1, 2011, Pages 88-94

  Motosugi, Utaroh ^a   Ichikawa, Tomoaki ^a   Sano, Katsuhiro ^a   Sou, Hironobu ^a   Onohara, Kojiro ^a   Muhi, Ali ^a   Amemiya, Fumitake ^a   Enomoto, Nobuyuki ^a   Matsuda, Masanori ^a   Fujii, Hideki ^a   Araki, Tsutomu ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

gadoxetic acid; hepatocellular carcinoma; liver; MR Imaging

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTERY; ARTICLE; BODY FAT; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; LIVER ARTERIOGRAPHY; LIVER BLOOD FLOW; LIVER CELL; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULARIZATION;

ADIPOSE TISSUE; CHRONIC DISEASE; COHORT STUDIES; CONTRAST MEDIA; DISEASE PROGRESSION; HUMANS; HYPERTENSION, PORTAL; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MAGNETICS; RETROSPECTIVE STUDIES; RISK; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959578200     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22630     Document Type: Article

References (32)

1. Sakamoto M, Hirohashi S, Shimosato Y,. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-178.
2. Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H,. CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 2007; 72 (Suppl 1): 83-91. (Pubitemid 350256670)
3. Yu JS, Chung JJ, Kim JH, Kim KW,. Hypervascular focus in the nonhypervascular nodule ("nodule-in-nodule") on dynamic computed tomography: imaging evidence of aggressive progression in hepatocellular carcinoma. J Comput Assist Tomogr 2009; 33: 131-135.
4. Winter TC III, Takayasu K, Muramatsu Y, et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 1994; 192: 379-387. (Pubitemid 24233914)
5. Efremidis SC, Hytiroglou P, Matsui O,. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007; 17: 2969-2982. (Pubitemid 47603995)
6. Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
7. Sherman M,. Diagnosis of small hepatocellular carcinoma. Hepatology 2005; 42: 14-16. (Pubitemid 40911304)
8. Zech CJ, Vos B, Nordell A, et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 2009; 44: 305-310.
9. Filippone A, Blakeborough A, Breuer J, et al. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging 2010; 31: 356-364.
10. Motosugi U, Ichikawa T, Sou H, et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 2010; 256: 151-158.
11. Motosugi U, Ichikawa T, Sou H, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 2009; 30: 1042-1046.
12. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005; 234: 468-478. (Pubitemid 40139918)
13. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L,. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009; 19 (Suppl 5): S975-989.
14. Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010; 45: 133-141.
15. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001; 79: 373-374.
16. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230: 266-275. (Pubitemid 37549812)
17. Jung G, Breuer J, Poll LW, et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47: 15-23. (Pubitemid 43177525)
18. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18: 457-467. (Pubitemid 351248177)
19. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO,. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008; 43: 504-511.
20. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997; 7: 275-280. (Pubitemid 127538595)
21. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200: 59-67. (Pubitemid 26197732)
22. Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010; 20: 2405-2413.
23. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801. (Pubitemid 23174709)
24. Beasley RP, Hwang LY, Lin CC, Chien CS,. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129-1133.
25. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-472. (Pubitemid 27078833)
26. Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF,. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997; 26: 1138-1142. (Pubitemid 27509294)
27. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S,. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 61-66.
28. Tradati F, Colombo M, Mannucci PM, et al. A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91: 1173-1177. (Pubitemid 28086869)
29. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M,. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000; 33: 282-289. (Pubitemid 30485232)
30. Takayasu K, Muramatsu Y, Mizuguchi Y, et al. CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. AJR Am J Roentgenol 2006; 187: 454-463. (Pubitemid 44148290)
31. Motosugi U, Ichikawa T, Tominaga L, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 2009; 19: 2623-2629.
32. Araki T, Itai Y, Furui S, Tasaka A,. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 1980; 135: 1037-1043. (Pubitemid 11236978)